Bank of America
AEON icon

Bank of America’s AEON Biopharma AEON Stock Holding History

Bank of America’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,382
Closed -$2.62K – 5708
2025
Q4 		$2.62K Buy
2,382
+6
+0.3% +$6 ﹤0.01% 6373
2025
Q3 		$1.92K Sell
2,376
-9
-0.4% -$7 ﹤0.01% 7406
2025
Q2 		$1.81K Buy
2,385
+66
+3% +$38 ﹤0.01% 7447
2025
Q1 		$1.34K Buy
2,319
+5
+0.2% +$36 ﹤0.01% 7383
2024
Q4 		$90K Hold
2,314
– – ﹤0.01% 6442
2024
Q3 		$175K Buy
2,314
+1,992
+619% +$175K ﹤0.01% 6070
2024
Q2 		$24.3K Buy
322
+3
+0.9% +$715 ﹤0.01% 6692
2024
Q1 		$267K Sell
319
-5
-2% -$3.62K ﹤0.01% 5732
2023
Q4 		$168K Hold
324
– – ﹤0.01% 6163
2023
Q3 		$131K Buy
+324
New +$148K ﹤0.01% 6126

Other funds holding AEON

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America's AEON Position: Q1 2026 in Review

Bank of America sold out of AEON Biopharma (AEON) in Q1 2026, closing a stake of 2,382 shares — an estimated $2.62K sold.

Bank of America first reported a position in AEON in Q3 2023 and held it in 10 quarters. The position peaked at $267K in Q1 2024. 24 funds tracked by Wall St. Rank hold AEON as of Q1 2026.

  • Bank of America reported no remaining AEON Biopharma position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 2,382 AEON Biopharma shares in Q1 2026, an estimated $2.62K.
  • Bank of America first reported a position in AEON Biopharma in Q3 2023 and held it in 10 quarters.
  • Bank of America's AEON Biopharma position peaked at $267K in Q1 2024.
  • 24 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.